Macrogenics Inc (NASDAQ: MGNX) is 55.51% higher on its value in year-to-date trading and has touched a low of $4.29 and a high of $21.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MGNX stock was last observed hovering at around $14.22 in the last trading session, with the day’s gains setting it 0.74%.
Currently trading at $14.96, the stock is -12.80% and -6.48% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.02 million and changing 5.20% at the moment leaves the stock 73.32% off its SMA200. MGNX registered 121.63% gain for a year compared to 6-month gain of 213.63%. The firm has a 50-day simple moving average (SMA 50) of $12.93 and a 200-day simple moving average (SMA200) of $366.58.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -13.33% loss in the last 1 month and extending the period to 3 months gives it a 47.97%, and is -2.79% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.96% over the week and 7.42% over the month.
Macrogenics Inc (MGNX) has around 339 employees, a market worth around $933.95M and $58.75M in sales. Profit margin for the company is -15.42%. Distance from 52-week low is 248.72% and -31.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-4.95%).
Macrogenics Inc quarterly earnings per share for the current quarter are estimated at -$0.62 with sales reaching $15.66M over the same period.The EPS is expected to shrink by -1599.84% this year, but quarterly earnings will post 13.70% year-over-year. Quarterly sales are estimated to shrink -36.10% in year-over-year returns.
198 institutions hold shares in Macrogenics Inc (MGNX), with institutional investors hold 102.72% of the company’s shares. The shares outstanding are 62.07M, and float is at 58.56M with Short Float at 9.57%. Institutions hold 99.99% of the Float.
The top institutional shareholder in the company is Bellevue Group AG with over 9.61 million shares valued at $51.41 million. The investor’s holdings represent 15.51% of the MGNX Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 6.0 million shares valued at $32.08 million to account for 9.68% of the shares outstanding. The other top investors are Armistice Capital, LLC which holds 5.6 million shares representing 9.04% and valued at over $29.96 million, while T. Rowe Price Investment Management, Inc. holds 8.82% of the shares totaling 5.46 million with a market value of $29.23 million.
Macrogenics Inc (MGNX) Insider Activity
The most recent transaction is an insider sale by Peters Jeffrey Stuart, the company’s Senior VP and General Counsel. SEC filings show that Peters Jeffrey Stuart sold 19,625 shares of the company’s common stock on Mar 06 ’24 at a price of $21.50 per share for a total of $0.42 million. Following the sale, the insider now owns 8895.0 shares.
Macrogenics Inc disclosed in a document filed with the SEC on Mar 04 ’24 that Risser Eric Blasius (Chief Operating Officer) sold a total of 41,159 shares of the company’s common stock. The trade occurred on Mar 04 ’24 and was made at $19.76 per share for $0.81 million. Following the transaction, the insider now directly holds 38900.0 shares of the MGNX stock.
Still, SEC filings show that on Mar 04 ’24, Karrels James (SVP, CFO and Secretary) disposed off 30,000 shares at an average price of $20.50 for $0.61 million. The insider now directly holds 171,452 shares of Macrogenics Inc (MGNX).
